ReviewFrontiers in immunology2026

O-GlcNAcylation at the tumor-immune interface: a metabolic post-translational code driving immune evasion and therapy resistance in cancer.

Shanshan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.